questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the use of artificial intelligence and digital tools within the NHS and the Medicines and Healthcare products Regulatory Agency to (a) detect potential dopamine agonist-related impulse control disorders and augmentation from prescribing and clinical records and (b) support earlier warnings and monitoring for patients at higher risk.
heading: Drugs: Side Effects